Craniomaxillofacial Implants Market
Facial fractures and its occurrence in every part of the world have strengthened the importance of craniomaxillofacial surgeries. Effective and durable fixation of injured oral, restoring natural shape and functions of jaw need, and improvement in facial and cranial bones are other factors contributing to this market’s growth. Traumas, accidents, and genetic defects lead to craniomaxillofacial deformities. Factors like the rising customization of craniomaxillofacial implants demand, growing aging population, and an increasing road accident number are boosting the craniomaxillofacial implants market.
The rising number of partnerships and collaborations and shifting trend of internal fixators from metallic to non-metallic and bio-absorbable material are major trends witnessed in the global craniomaxillofacial implants market. Additionally, the rising number of craniomaxillofacial surgery centers worldwide is playing a crucial role in enhancing awareness about CMF implants and related surgeries, which is further anticipated to boost this market. Moreover, patient-specific implants, rising demand for bioresorbable materials, growing adoption of robot-assisted with simplified CMF surgeries, advanced techniques like computer-assisted craniofacial reconstruction, endoscopic procedures coupled with refinements in surgical equipments like resorbable plating and distractors have improved the surgical outcomes and decreased morbidity. However, the expensive CMF surgeries and the lack of apt health insurance schemes, especially in the developing nations, may limit this market.
The craniomaxillofacial implants market is fragmented on the basis of product into mandibular orthognathic implants, distraction systems, bone graft substitutes, temporomandibular joint (TMJ) replacement devices, cranial flap fixation systems, dural repair products, thoracic fixation systems, and others. By material, the craniomaxillofacial implants market includes metals and alloys, calcium ceramics, biologic materials, polymers, and others. Based on location, the market includes internal and external fixators. On the basis of nature, the market is divided into non-resorbable and resorbable fixators. By application, the craniomaxillofacial implants market includes orthognathic and dental surgery, plastic surgery, and neurosurgery and ENT.
North America dominated the global craniomaxillofacial implants market in 2018, due to a considerable rise in the number of craniomaxillofacial surgeries, especially in the U.S. As per the American Association for the Surgery of Trauma, CMF injuries account for about 150,000 annual deaths in the U.S. Additionally, a huge aging population base, promising healthcare schemes listed by government agencies, and the high prevalence rate of hereditary facial abnormalities are further propelling the North American market growth. The National Crime Records Bureau reported more than 120,000 annual deaths in India, i.e., the worst road accident rate in the entire Asia Pacific region. The rising number of car accidents in China, India, and Japan is likely to drive the Asia Pacific craniomaxillofacial implants market.
Some leading players in the global craniomaxillofacial implants market are Johnson & Johnson Services, B. Braun Melsungen, KLS Martin, Integra LifeSciences Holdings, Zimmer Holding, Stryker Corporation, Osteomed L.P., Matrix Surgical USA, Medtronic, and CONMED.